GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Apures Co Ltd (XKRX:149300) » Definitions » EPS (Diluted)

Apures Co (XKRX:149300) EPS (Diluted) : ₩-133.00 (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Apures Co EPS (Diluted)?

Apures Co's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was ₩-133.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-133.00.

Apures Co's EPS (Basic) for the six months ended in Dec. 2023 was ₩-133.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-133.00.

Apures Co's EPS without NRI for the six months ended in Dec. 2023 was ₩-130.04. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-130.04.

During the past 3 years, the average EPS without NRIGrowth Rate was 10.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 10 years, Apures Co's highest 3-Year average EPS without NRI Growth Rate was 14.20% per year. The lowest was -20.60% per year. And the median was 3.00% per year.


Apures Co EPS (Diluted) Historical Data

The historical data trend for Apures Co's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apures Co EPS (Diluted) Chart

Apures Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -289.00 -409.00 -83.00 -144.00 -133.00

Apures Co Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only -289.00 -409.00 -83.00 -144.00 -133.00

Competitive Comparison of Apures Co's EPS (Diluted)

For the Diagnostics & Research subindustry, Apures Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apures Co's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Apures Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Apures Co's PE Ratio falls into.



Apures Co EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Apures Co's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-5183.439-0)/38.973
=-133.00

Apures Co's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-5183.439-0)/38.973
=-133.00

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-133.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Apures Co  (XKRX:149300) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Apures Co EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Apures Co's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Apures Co (XKRX:149300) Business Description

Traded in Other Exchanges
N/A
Address
44, Hansan-gil, Cheongbuk-eup, Gyeonggi-do, Pyeongtaek-si, KOR, 17792
Apures Co Ltd is a South Korea based company engaged in the development of transgenic animals to support bio heterogeneous long-term commercialization and new drug efficacy research. It has focused its research capabilities on developing transgenic mini pigs based on gene editing technology and somatic cell nuclear transfer technology.

Apures Co (XKRX:149300) Headlines

No Headlines